April 14, 2021
Working from home is becoming an increasingly widespread practice, and FDA-regulated industry is no exception. Even post-pandemic, it is likely that some staff in many companies will continue to work remotely for various logistical reasons. Some study activities must be observed in-person, but it is possible for quality assurance personnel to conduct a portion of study audits virtually. This poster will discuss auditing different types of data remotely, advantages and disadvantages of a work-from-home setup for quality assurance personnel, and the practical equipment and personnel commitments necessary to streamline the process.
Presented at the Society of Quality Assurance 37th Annual Meeting - Virtual